Lubrizol Life Science Health is the preferred Contract Development and Manufacturing Organization (CDMO) for complex drug products. We specialize in taking clients from concept through commercialization with:*Solubility & Bioavailability Enhancement (particle size reduction/nanomilling, amorphous solid dispersions, nanoparticle/microparticle encapsulation, etc...)*Sterile Products (parenteral products, ophthalmic drugs, otic dosage forms, implantable products)*Long-Acting Drug Delivery (microsphere and gel depot injections, implantable devices, combination products)*Highly Potent APIs and Controlled Substances (hormones, cytotoxics, steroids, schedule I-V substances) *Long-standing polymer capabilities and innovative excipients that provide unique attributes to many dosage forms (Carbopol®, Pemulen™, Noveon® polycarbophil, and Pathway™ TPU)Lubrizol LifeSciences, a Berkshire Hathaway company, is a leader in polymer-based delivery systems leveraging our history of success using TPU (Thermoplastic Polyurethane) and polyacrylic acid polymers (Carbopol®, Noveon® AA-1, Pemulen™) to drive new solutions in the medical device and pharmaceutical markets.